Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. Cragg
High Expression of BCL-2 and BCL-Xl in Diffuse Large B-Cell Lymphoma Confer Poor Prognosis but May Be Reversible by Combined Inhibition With Bet Inhibitors and Bh3 Mimetics.
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Related publications
BCL-2 Protein Frequency in Patients With High-Risk Diffuse Large B-Cell Lymphoma
Sao Paulo Medical Journal
Medicine
Combination of BCL-2 and MYC Protein Expression Improves High-Risk Stratification in Diffuse Large B-Cell Lymphoma
OncoTargets and Therapy
Oncology
Pharmacology
Frequent Expression of CD10 and BCL-6 in High-Grade Primary Extranodal Lymphoma With Diffuse Large B-Cell Lymphoma Morphology
Journal of clinical and experimental hematopathology : JCEH
Medicine
Apoptosis Is Augmented in High-Grade Serous Ovarian Cancer by the Combined Inhibition of BCL-2/BCL-xL and PARP
International Journal of Oncology
Cancer Research
Oncology
Combined Inhibition of Notch Signaling and BCL-2/BCL-xL Results in Synergistic Antimyeloma Effect
Molecular Cancer Therapeutics
Cancer Research
Oncology
The BCL-2 Protein Family, BH3-mimetics and Cancer Therapy
Cell Death and Differentiation
Cell Biology
Molecular Biology
Combined MEK and BCL-XL Inhibition Kills KRAS -Mutant Cells
Cancer Discovery
Oncology
Proteasome and HDAC Inhibition Changes the Expression Levels of BCL-2, BCL-Xl, Bim and Bik Proteins in Androgen-Independent PC-3 Cell Line
Gazi Medical Journal
Medicine
Structure-Based Design of Potent BCL-2/BCL-xL Inhibitors With Strong in Vivo Antitumor Activity
Journal of Medicinal Chemistry
Drug Discovery
Molecular Medicine
